内镜下袖状胃成形术治疗肥胖与代谢病的研究进展  

Advances in endoscopic sleeve gastroplasty for the treatment of obesity and metabolic disease

作　　者：董世梁 周福庆 陈文辉 王存川[1] 董志勇 Dong Shiliang;Zhou Fuqing;Chen Wenhui;Wang Cunchuan;Dong Zhiyong(Department of Gastrointestinal Surgery,Department of Bariatric Surgery,the First Affiliated Hospital,Ji'nan University,Guangzhou 510630,China)

机构地区：[1]暨南大学医学院第一附属医院胃肠外科/减重中心,广州510630

出　　处：《中华胃肠外科杂志》2023年第8期803-806,共4页Chinese Journal of Gastrointestinal Surgery

基　　金：广东省高水平医院建设项目(JNU1AF-CFTP-2022-a01202)。

摘　　要：肥胖症严重威胁着人类的健康,减重手术作为病态肥胖患者安全有效的治疗方法,尽管疗效已得到证实,但其手术风险和高昂的医疗成本限制了其在临床的应用和普及。内镜下袖状胃成形术(ESG)作为一种相对新的内镜减重手术技术,与腹腔镜袖状胃切除术相比,ESG在减重方面具有令人满意的效果,而且保留了胃的正常结构,且已经在国外多中心研究得到验证。但目前国内尚未广泛开展ESG,但随着这一术式的逐渐成熟,其前景值得减重领域同仁关注。未来国内也亟待开展大规模、长期、多中心的研究来明确,ESG手术在中国肥胖与代谢病患者中的远期效果、合并症缓解以及并发症发生情况。Obesity poses a serious threat to human health,and although bariatric surgery has been proven effective treatment for morbidly obese patients,its surgical risks and high medical costs limit its clinical application and popularity.Endoscopic sleeve gastroplasty(ESG),as a relatively new endoscopic surgery technique for weight loss,has satisfactory weight loss effects compared to laparoscopic sleeve gastrectomy and lifestyle interventions,while preserving the normal structure of the stomach.Its weight loss effects and safety have been validated in multicenter studies abroad.Although,ESG has not yet been widely performed in China,with the gradual maturity of this technique,its prospects are worth attention in the field of weight loss.In the future,large-scale,long-term,multi-center studies are urgently needed in China to clarify the long-term effects,remission of comorbidities,and occurrence of complications of ESG surgery in obese and metabolic disease patients.

关 键 词：肥胖 减重手术 内镜下袖状胃成形术 腹腔镜袖状胃成形术 

分 类 号：R656.61[医药卫生—外科学]